{
  "success": true,
  "pagesUsed": [
    2,
    4,
    10,
    12,
    15,
    17,
    20,
    25,
    27,
    29,
    32,
    37,
    39,
    40,
    41,
    42,
    57
  ],
  "modelUsed": "gemini-2.5-pro",
  "confidence": 1.0,
  "scheduling": {
    "timings": [
      {
        "id": "timing_1",
        "name": "Zinc Washout Period",
        "type": {
          "id": "2a212985-87d2-438d-b72c-becdc24ea314",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P21D",
        "valueLabel": "Day 21",
        "relativeToFrom": {
          "id": "73a31663-86a7-427c-ad22-7d6dbcb1f44a",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "78db8c82-4c0a-463c-8622-8f8c3600ce51",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_2",
        "name": "Tetrathiomolybdate Washout Period",
        "type": {
          "id": "47ea9b70-14ce-4229-83e3-773398bbf541",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P1D",
        "valueLabel": "1 years",
        "relativeToFrom": {
          "id": "964249ec-cd66-47f3-8b96-788dd9850b59",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "30a33655-7212-4dc8-8107-03607a1a3b1f",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_3",
        "name": "Experimental Therapy Washout Period",
        "type": {
          "id": "fe202bef-f7ba-4734-ba8e-7cef5de3c0cc",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P90D",
        "valueLabel": "Day 90",
        "relativeToFrom": {
          "id": "14e776da-8431-4f44-90d0-847774d3bffa",
          "code": "C71158",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Screening",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "9dc0edb9-e173-401b-bb50-d4600a9a5ffd",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_4",
        "name": "Prescription Medication Washout",
        "type": {
          "id": "01a3ed82-4fe1-492c-97dc-506ee5420953",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P14D",
        "valueLabel": "Day 14",
        "relativeToFrom": {
          "id": "8021e977-02db-4c86-93cc-338fef3abad8",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "cdace78c-ad22-4507-b135-71f64804532d",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_5",
        "name": "Non-Prescription Medication Washout",
        "type": {
          "id": "0ab510c1-73f4-44ed-a553-148989073ae4",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P7D",
        "valueLabel": "Day 7",
        "relativeToFrom": {
          "id": "8b9dddfb-0a26-46ba-8894-e65541738d7e",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "2b92cc16-50c8-4165-bdcf-ae770918c5b7",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_6",
        "name": "End of Study Visit Window",
        "type": {
          "id": "0d4e6c1c-77a8-46b0-84c7-254201e8fa62",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P54D",
        "valueLabel": "Day 54",
        "relativeToFrom": {
          "id": "83aba26c-8d42-4dce-9f24-8ae3f603a1dc",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "5a4be756-4a49-4669-adb0-17bda825d198",
        "instanceType": "Timing",
        "windowLower": "-P2D",
        "windowUpper": "P2D"
      },
      {
        "id": "timing_7",
        "name": "Dose Titration Timing",
        "type": {
          "id": "8635f014-040e-48d9-8da9-5ea35779bea2",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P29D",
        "valueLabel": "Day 29",
        "relativeToFrom": {
          "id": "d921be65-cacb-4d20-8bff-12f1fa564e47",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "5722f5cb-d085-4d4b-a513-cfefc8fff887",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_8",
        "name": "Chelator Discontinuation Prior to Baseline",
        "type": {
          "id": "5b938509-6f9b-40be-b6aa-282b27028c51",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P4D",
        "valueLabel": "Day 4",
        "relativeToFrom": {
          "id": "cd9e89e5-7b81-42e1-aa7a-d5d63bb96b43",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "e1de4195-0049-4c7a-95a7-3ceb5b355ab0",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_9",
        "name": "Alcohol Abstinence",
        "type": {
          "id": "9a2816c5-8354-408d-ae40-8d9e6953fabc",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "PT48H",
        "valueLabel": "48 hours",
        "relativeToFrom": {
          "id": "9035939e-7d9c-4854-86be-1e9c9c07752e",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "beee98a9-e22d-4557-a06d-cb939fb761cc",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      }
    ],
    "conditions": [
      {
        "id": "cond_1",
        "name": "ALT Elevation for Dose Interruption",
        "instanceType": "Condition",
        "description": "Alanine aminotransferase (ALT) level that triggers temporary dose interruption.",
        "text": "ALT > 3 × ULN and ≤ 5 × ULN"
      },
      {
        "id": "cond_2",
        "name": "ALT Elevation for Discontinuation",
        "instanceType": "Condition",
        "description": "Alanine aminotransferase (ALT) level that triggers permanent discontinuation of study drug.",
        "text": "ALT > 5 × ULN"
      },
      {
        "id": "cond_3",
        "name": "Neutropenia for Dose Reduction",
        "instanceType": "Condition",
        "description": "Neutrophil count decrease that triggers a dose reduction.",
        "text": "Neutrophils > 30% decrease from baseline and below reference range at baseline"
      },
      {
        "id": "cond_4",
        "name": "Potential Liver Injury for Interruption",
        "instanceType": "Condition",
        "description": "Combination of bilirubin and ALT elevation indicative of liver injury that triggers temporary dose interruption.",
        "text": "Bilirubin > 2 × ULN accompanied by ALT > 3 × ULN"
      },
      {
        "id": "cond_5",
        "name": "Neurologic Worsening",
        "instanceType": "Condition",
        "description": "Evidence of neurologic worsening that triggers an evaluation for dose modification.",
        "text": "Evidence of neurologic worsening by AEs or by neurologic physical exam assessment"
      },
      {
        "id": "cond_6",
        "name": "Psychiatric Worsening",
        "instanceType": "Condition",
        "description": "Evidence of psychiatric worsening that triggers an evaluation for dose modification.",
        "text": "Evidence of clinically significant acute psychiatric worsening which may include but not limited to suicidality, acute depression, or psychosis."
      },
      {
        "id": "cond_7",
        "name": "Safety Review for Dose Titration",
        "instanceType": "Condition",
        "description": "A safety review must be completed before dose titration can occur.",
        "text": "Before titration to 30 mg/day, the Safety Review Committee (SRC) will review available safety data through Day 23 for each participant."
      },
      {
        "id": "cond_8",
        "name": "Outpatient Period Extension",
        "instanceType": "Condition",
        "description": "Condition allowing for an adaptive extension of the outpatient period.",
        "text": "The Outpatient Period during Treatment Period 1 may be extended up to an additional 14 days with Investigator approval."
      }
    ],
    "conditionAssignments": [],
    "transitionRules": [
      {
        "id": "trans_1",
        "name": "Dose Titration to 30 mg/day",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "fromElementId": "dose_15mg",
        "toElementId": "dose_30mg",
        "text": "Following the Run-in Period, participants will be administered ALXN1840 at 15 mg/day for a treatment period of approximately 28 days followed by titration up to 30 mg/day on Day 29."
      },
      {
        "id": "trans_2",
        "name": "Dose Titration Hold",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Participants may remain on the 15 mg/day dose for the duration of the study if there are safety concerns that, in the opinion of the Investigator(s) and/or Alexion, may place participants at undue risk."
      },
      {
        "id": "trans_3",
        "name": "Dose Interruption for ALT Elevation",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Temporary interruption of dosing for ALT > 3 × ULN and ≤ 5 × ULN."
      },
      {
        "id": "trans_4",
        "name": "Dose Reduction for Neutropenia",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Reduce dose to previous dose level or to 15 mg QOD if on 15 mg QD for Neutrophils > 30% decrease from baseline."
      },
      {
        "id": "trans_5",
        "name": "Discontinuation for Severe ALT Elevation",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Discontinuation of study intervention for ALT > 5 × ULN."
      },
      {
        "id": "trans_6",
        "name": "Discontinuation for Hypersensitivity",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention for a serious hypersensitivity reaction."
      },
      {
        "id": "trans_7",
        "name": "Discontinuation for Severe Infection",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention for a severe uncontrolled infection."
      },
      {
        "id": "trans_8",
        "name": "Discontinuation for Disallowed Medication",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention for use of disallowed medication."
      },
      {
        "id": "trans_9",
        "name": "Discontinuation for Pregnancy",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention for pregnancy or planned pregnancy."
      }
    ],
    "scheduleTimelineExits": [
      {
        "id": "exit_1",
        "name": "Study Completion",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant is considered to have completed the study if he/she has completed all phases of the study including the last scheduled procedure shown in the Schedule of Activities (SoA)."
      },
      {
        "id": "exit_2",
        "name": "Participant Withdrawal of Consent",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant may withdraw from the study at any time at his/her own request."
      },
      {
        "id": "exit_3",
        "name": "Investigator Discretionary Withdrawal",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant may be withdrawn at any time at the discretion of the Investigator for safety, behavioral, compliance, or administrative reasons."
      },
      {
        "id": "exit_4",
        "name": "Lost to Follow-up",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant will be considered lost to follow-up if he or she repeatedly fails to return for scheduled visits and is unable to be contacted by the study site after documented attempts."
      },
      {
        "id": "exit_5",
        "name": "Sponsor Termination of Study",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Alexion reserves the right to close the study site or terminate the study at any time for any reason at the sole discretion of Alexion."
      }
    ],
    "scheduledDecisionInstances": [
      {
        "id": "dec_1",
        "name": "Dose Titration Decision",
        "timepointId": "pt_day23_review",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point prior to Day 29 to determine if a participant can be titrated from 15 mg/day to 30 mg/day based on a review of safety data through Day 23.",
        "conditionIds": [
          "cond_7"
        ]
      },
      {
        "id": "dec_2",
        "name": "Ongoing Safety Monitoring Decision",
        "timepointId": "pt_ongoing",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Ongoing assessment of safety parameters (liver function, blood counts, neurologic and psychiatric status) that may trigger dose modification or discontinuation at any time during the study.",
        "conditionIds": [
          "cond_1",
          "cond_2",
          "cond_3",
          "cond_4",
          "cond_5",
          "cond_6"
        ]
      }
    ],
    "summary": {
      "timingCount": 9,
      "conditionCount": 8,
      "transitionRuleCount": 9,
      "exitCount": 5
    }
  }
}